4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-103382
Director sold 31,300 shares at an average $45.59 ($1,427,063)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-30 | Sale 10b5-1 | −25,096 | $45.49 | $1,141,617 | 406,204 | I |
| Kersten Dirk Director | 2024-08-30 | Sale 10b5-1 | −6,204 | $46.01 | $285,446 | 400,000 | I |
| Open-market sales · 31,300 sh · avg $45.59 · $1,427,063 | |||||||
Loading xslF345X05/ownership.xml…